Instem at ACT 2022

News & Events

In this section

Instem at ACT 2022 - Gold Sponsor

Helping our clients bring their life enhancing products to market faster

Please stop by one of our booths to learn more about Instem’s powerful software solutions & services

Preclinical Solutions - Booth #205

Learn how Instem’s preclinical solutions keep our clients focused on their science, not their software.

Provantis® is the #1 online solution for managing preclinical studies.
Learn about submit™, the most widely adopted modular software suite for creating, reviewing and managing SEND data or ask our SEND experts about our new SEND Advantage services.
Our Genetic Tox Solutions are in a class of their own, featuring Comet Assay IV and Cyto Study Manager.

In Silico Solutions - Booth #207

Learn how our software and outsourced services enable researchers to generate new scientific insights through the identification, extraction and analysis of data to create actionable information.

KnowledgeScan™ Target Safety Assessment (TSA) Service: Delivering comprehensive TSAs for clients around the world, enabling them to make faster, better-informed decisions on their drug targets.
Leadscope Model Applier: Easy-to-use software to apply prediction models, perform an expert review, and create reports.
Genetic Toxicity (Q)SARs: Complete solutions for the computational assessment of genetic toxicity, including statistical-based and expert rule-based models.
Predict™: A leading edge, technology-enabled service that delivers a combination of powerful computation models with expert scientific review, to help clients predict chemical safety more quickly, efficiently, and comprehensively.

Industry Workshop & Luncheon

Assessing and communicating the developing safety profile of a new product – what do we need and how do we find it?

When? Tuesday November 15th, 1pm-2pm (lunch will be provided)
Where? Crest 5, Gaylord Rockies Hotel

Join Brenda Finney, PhD, Instem’s Director of Translational Solutions and our panel of experts from organizations including AstraZeneca, Bristol Myers Squibb, GSK and Novartis, for an interactive workshop to discuss best practices and challenges facing project toxicologists in gathering and reviewing study data across a development programme.

During the workshop, we will discuss the current practices and tools used when working with the data associated with a new therapeutic. These discussions will allow attendees to explore and assess the processes and information needs of toxicologists charged with monitoring and submitting safety assessments throughout the development lifecycle of a new therapeutic.

Talking Tox Presentations

Strategic In Silico: Creating Powerful New Scientific Insights. Presented by Gordon Smith Baxter, PhD, Chief Scientific Officer and Glenn Myatt, PhD, Vice President, Informatics.

Tuesday, November 15th, 12.00-12.55pm (MST) Room: Summit 7

News & Events